Differences

This shows you the differences between two versions of the page.

--- content:aicardi_syndrome [2020/02/23 00:47] – icna
+++ content:aicardi_syndrome [2020/02/23 00:51] – icna
@@ Line 1: / Line 1: @@
 ====== Aicardi syndrome ======
-{{page>template:todo}}
 A rare neurodevelopmental disorder characterized by the classic triad of agenesis of the corpus callosum (total or partial), central chorioretinal lacunae and infantile spasms that affects almost exclusively females & rarely in 47 XXY males. However Aicardi syndrome is now recognized as a more complex, pleiotropic disorder with an expanded spectrum of phenotypical features.
 ===== Clinical features =====
@@ Line 37: / Line 36: @@
 ==== Genetics ====
   * Nearly all reported cases of Aicardi syndrome are sporadic and in females and believed to result from new gene mutations
-  * Aicardi syndrome is classified as an X-linked dominant condition[{{ :content:xlinkdominant.jpeg?300|Credit:U.S National Library of Medicine}}.
+  * Aicardi syndrome is classified as an X-linked dominant condition[{{ :content:xlinkdominant.jpeg?300|Credit:U.S National Library of Medicine}}].
-  * mutation in gene [[https://www.genecards.org/cgi-bin/carddisp.pl?gene=TEAD1|TEAD1]] was the first genetic mutation reported to be associated with Aicardi syndrome[(:cite:>{{pubmed>long:26091538}})]. TEAD1 mutations has also been shown to be present in males[(:cite:>{{pubmed>long:26091538}})].
+  * mutation in gene [[https://www.genecards.org/cgi-bin/carddisp.pl?gene=TEAD1|TEAD1]] was the first genetic mutation reported to be associated with Aicardi syndrome[(:cite:26091538>{{pubmed>long:26091538}})]. TEAD1 mutations has also been shown to be present in males[(:cite:26091538>{{pubmed>long:26091538}})].
 === Neuroimaging ===